SATL1 and prostate carcinoma: To further explore the possibility that these genes are meiCT genes, we used 11 of the 14 genes for meta-analyses using the 80 cancer gene expression microarray data sets (3 were not present on the microarrays, C1orf141, HEATR7B and SATL1) and found expression profiles for 5 of these genes were indicative of a cancer type marker for ovarian and prostate cancers (45.5%; Figure 5).